| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536939 | Vaccine | 2017 | 8 Pages |
Abstract
Overall, robust IgG and OPA immunological responses were observed after booster vaccination with PCV13 in children primed with 2 or 3 doses of PHiD-CV or PCV13, including for serotypes not included in PHiD-CV. These results suggest that these vaccines are interchangeable in terms of safety and immunogenicity and that PCV13 can be used as a booster in the context of mixed schedules. (EudraCT numbers: 2012-005366-35 and 2012-005367-27).
Keywords
serious AEPHiD-CVGMTPCV13GMCPCV7SAEImmunogenicityimmunisation scheduleELISAEnzyme-linked immunosorbent assayinterchangeabilitySerotype 19Aadverse eventconfidence intervalGeometric mean concentrationGeometric mean titer7-valent pneumococcal conjugate vaccinePneumococcal conjugate vaccine13-Valent pneumococcal conjugate vaccine
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ingrid Urbancikova, Roman Prymula, David Goldblatt, Lucy Roalfe, Karolina Prymulova, Pavel Kosina,